Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Launched by BAPTIST HEALTH SOUTH FLORIDA · Aug 15, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how a special app called Brainlab Cognition can be used to assess brain function in patients with central nervous system tumors. The study aims to see if this app can be effectively used in a cancer clinic setting and if patients can easily share information about their quality of life through electronic means. It’s an important step in understanding how brain tumors and treatments affect cognitive health and daily living.

To participate, you must be an adult (18 years or older) with a brain tumor who has received treatments like radiation or surgery at the Miami Cancer Institute. You should also expect to live for at least six more months and be willing to take part in this ongoing study. If you join, you’ll use the app to provide information about your brain function and quality of life, helping researchers learn more about the needs of patients like you. It's a chance to contribute to important research while staying connected with your healthcare team.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
• • 2. Life expectancy ≥ 6 months
• • 3. Willingness to participate in ongoing registration study
• Exclusion Criteria:
• • 1. Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
• • 2. Pediatric patients (\<18 years old), pregnant women, and prisoners.